SLC2A1 and Parkinson disease: Recent studies conducted by our research group reported that the knock‐down of EAAT3 abolished the neuroprotection induced by Glut in different pathological settings, such as PD‐like model, AD‐like models and a model of neuronal hypoxia‐reoxygenation injury [20, 32, 47].